The Solution

Draht expertise (team developed and licensed the current industry leading product) addresses each complication

• Safety- designed with variable stiffness to optimize safety, reducing risk of left Ventricular perforation, and subsequent pericardial tamponade. It will not require a) catheter based venous pacing reducing radiation exposure, risk of vascular bleeding, thrombosis, and infection or b) product modification (manual coating removal) reducing risk of pacing loss.

• Efficacy - Designed to facilitate support for valves and devices that can be re-positioned, increasing procedural effectiveness by maintaining position for device delivery. Pacing capability will also be implemented, eliminating the need for venous pacing - saving procedural time, and eliminating the need for separate access, delivery and pacing devices. 

Subsequent designs address the current TAVR valve deployment risks of high-grade AV Block or other AV conduction disturbances (due to aortic annulus stretching which can impingement on critical nearby conduction tissue). This occurs unpredictably and in various degrees of severity. Draht design will include A-V conduction monitoring to prevent this complication, which in some cases require a permanent pacemaker implant to resolve.